IBD Treatment Landscape

Topic outline

• Select topic IBD Treatment Landscape

  IBD Treatment Landscape

  In this module, we will highlight clinical practice guidelines and will explore, at class level, conventional and advanced treatments for IBD. We will also review the concept of therapeutic drug monitoring (TDM) when caring for patients with IBD.
• Select topic Introduction to IBD Medication Classes

  Introduction to IBD Medication Classes

  In these short, self-guided overviews, you will learn about IBD medication classes, including when they were introduced, mechanism of action, links to patient resources on explaining medication options for IBD and HCP resources regarding understanding medical management of IBD.

  Aminosalicylates
  Anti-Integrins
  Anti-TNFs

  Corticosteroids
  Immunomodulators
  Interleukin Inhibitors

  JAK Inhibitors
  S1P Receptor Modulators

  Learn more
• Select topic Conventional IBD Treatment

  Conventional IBD Treatment

  In this chapter, we’ll explore the classes of conventional treatments available when caring for patients with IBD, focusing specifically on aminosalicylates, corticosteroids, and immunomodulators. We will also explain how these came to be a part of the practitioner’s tool kit for disease management.

  Presented by Kimberly Kearns, MS, APN-BC

  Date recorded: May 2024

  Presenter

  

  Kimberly Kearns, MS, APN-BC

  Duration

  20:01 minutes

  Learn more
• Select topic Determining Prognosis and Monitoring of Therapies in IBD

  Determining Prognosis and Monitoring of Therapies in IBD

  In this chapter, you will receive a comprehensive review of advanced monitoring techniques, including therapeutic drug monitoring (TDM), for managing biologic therapy. This presentation also includes an analysis of advanced personalized medicine approaches in IBD treatment, including assessing biomarkers and genetics.

  Presented by Andres J. Yarur, MD

  Date recorded: May 2024

  Presenter

  

  Andres J. Yarur, MD

  Duration

  21:25 minutes

  Learn more
• Select topic STRIDE-II Recommendations

  STRIDE-II Recommendations

  Read the latest consensus-based recommendations for treat-to-target approaches in IBD.

  STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target Strategies in IBD

  Learn more
• Select topic Clinical Guidance for Crohn’s Disease

  Clinical Guidance for Crohn’s Disease

  Here you will find quick links to a few of the clinical practice guidelines for the management of Crohn’s disease (CD) from US-based medical associations.

  ACG Clinical Guideline: Management of Crohn’s Disease in Adults

  AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease

  AGA Spotlight: Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

  Learn more
• Select topic Clinical Guidance for Ulcerative Colitis

  Clinical Guidance for Ulcerative Colitis

  Here you will find quick links to a few of the clinical practice guidelines for the management of ulcerative colitis (UC) from US-based medical associations.

  ACG Clinical Guideline: Management of Ulcerative Colitis in Adults

  AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis

  AGA’s Mild-to-Moderate Clinical Decision Support Tool

  AGA Living Guideline for Moderate-to-Severe Ulcerative Colitis (overview with additional resources)

  AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis (full guidance)

  Learn more
• Select topic More is on the way

  More is on the way

  Highlighted

  When it comes to IBD, there’s a lot to cover, and we’ve only begun to scratch the surface. We’re always working on new educational content to help you stay ahead of the curve, so check back often.

  Create an account to receive updates

  Available from 3 December 2050

  Create an account to access